Core Viewpoint - Lin Qingxuan (02657) has announced the results of its global offering, raising a total of HKD 997 million through the issuance of approximately 13.9665 million H-shares at a price of HKD 77.77 per share [1] Group 1: Offering Details - The global offering consists of approximately 13.9665 million H-shares, with 10% allocated for public offering in Hong Kong and 90% for international offering [1] - The subscription for the Hong Kong public offering was oversubscribed by 1,235.81 times, while the international offering was oversubscribed by 19.79 times [1] - Each board lot consists of 50 H-shares, and trading is expected to commence on December 30, 2025, at 9:00 AM on the Hong Kong Stock Exchange [1]

智通财经APP讯，林清轩(02657)公布配发结果，公司全球发售约1396.65万股H股，香港公开发售占 10%，国际发售占90%。每股发售价77.77港元，全球发售净筹9.97亿港元。每手50股H股，预期H股将 于2025年12月30日上午9时正开始在联交所买卖。 其中，香港公开发售获1235.81倍认购，国际发售获19.79倍认购。 ...

格隆汇12月29日丨林清轩(02657.HK)公告，公司全球发售13,966,450股H股，每股H股77.77港元，所得 款项净额9.97亿港元。香港公开发售股份数目占全球发售股份数目10%，获认购1235.81倍；国际发售股 份数目占全球发售股份90%，获认购倍19.79倍。 假设香港公开发售于2025年12月30日(星期二)上午8时正或之前在香港成为无条件，预期H股将于2025年 12月30日(星期二)上午9时正开始在联交所买卖。H股将以每手买卖单位50股H股买卖，而H股的股份代 号将为2657。 ...

香 港 交 易 及 結 算 所 有 限 公 司、香 港 聯 合 交 易 所 有 限 公 司（「聯交所」）及香港中央結算有 限公司（「香港結算」）對 本 公 告 的 內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示 概 不 就 因 本 公 告 全 部 或 任 何 部 分 內 容 而 產 生 或 因 倚 賴 該 等 內 容 而 引 致 的 任 何 損 失 承 擔 任 何 責 任。 除 本 公 告 另 有 界 定 者 外，本 公 告 所 用 詞 彙 與 上 海 林 清 軒 化 妝 品 集 團 股 份 有 限 公 司（「本 公 司」）所刊發日期為2025年12月18日（星 期 四）的招股章程（「招股章程」）所界定者具有相 同 涵 義。 本 公 告 僅 供 參 考，並 不 構 成 任 何 人 士 收 購、購 買 或 認 購 本 公 司 任 何 證 券 的 要 約 或 誘 使 作 出 要 約 的 邀 請。本 公 告 並 非 招 股 章 程。有 意 投 資 者 於 決 定 是 否 投 資 發 售 股 份 前，應 細 閱 招 股 章 程，以 了 解 下 文 所 述 ...

Core Viewpoint - Lin Qingxuan has successfully completed its IPO, becoming the "first high-end domestic skincare stock" in the Hong Kong market, reflecting strong market interest and investor confidence in its growth story and fundamentals [1][2]. Group 1: IPO Details - Lin Qingxuan's IPO involved the issuance of 13.9665 million shares, with 10% allocated for Hong Kong and 90% for international offerings, aiming to raise HKD 1.086 billion at a price of HKD 77.77 per share [1]. - The company experienced an oversubscription of over 1,032 times, with total subscriptions reaching approximately HKD 112.13 billion, indicating high demand from investors [1]. - On the eve of its listing, Lin Qingxuan's shares saw a significant increase in the dark market, closing up 18.75% at HKD 92.35 [1]. Group 2: Market Position and Strategy - Lin Qingxuan has strategically positioned itself in the high-growth "high-end anti-wrinkle" segment, focusing on the "oil-based skincare" concept with its core product, Camellia Oil, which has dominated the retail market for facial oils in China for 11 consecutive years [4]. - The anti-wrinkle skincare market in China is projected to reach RMB 119.8 billion by 2024, with a compound annual growth rate (CAGR) of 15.0%, significantly outpacing the overall skincare market growth of 6.8% [4]. Group 3: Technological and Competitive Advantages - The company has established a robust technological and industrial chain barrier centered around "cell-level anti-wrinkle" technology, ensuring a competitive edge that is difficult to replicate [5]. - Lin Qingxuan has over 600 formula patents and 87 patents, including 46 invention patents, covering key areas such as Camellia extraction and anti-wrinkle repair technology [5]. Group 4: Financial Performance - From 2022 to 2024, Lin Qingxuan's revenue is expected to grow from RMB 690 million to RMB 1.21 billion, achieving a CAGR of 32.3%, surpassing the industry average [6]. - In the first half of 2025, the company reported revenue of RMB 1.052 billion, a year-on-year increase of 98.3%, with a net profit nearing RMB 182 million [6]. - The company's gross margin has shown consistent improvement, with figures of 78.0%, 81.2%, 82.5%, and 82.4% from 2022 to the first half of 2025, indicating strong operational effectiveness [6]. Group 5: Future Outlook - Lin Qingxuan plans to utilize the raised funds for brand building, marketing, channel expansion, R&D, and operational enhancements, which are expected to deepen its competitive moat and facilitate further growth [7].

Core Viewpoint - Lin Qingxuan has successfully completed its IPO, becoming the "first high-end domestic skincare stock" in the Hong Kong market, reflecting strong market interest and investor confidence in its growth story and fundamentals [1][2]. Group 1: IPO Details - Lin Qingxuan's IPO involved the issuance of 13.9665 million shares, with 10% allocated for Hong Kong and 90% for international investors, aiming to raise HKD 1.086 billion at a price of HKD 77.77 per share [1]. - The company experienced an oversubscription of over 1,032 times, with total subscriptions reaching approximately HKD 112.13 billion, indicating high demand from investors [1]. - On the eve of its listing, Lin Qingxuan's shares saw a significant increase in the dark market, closing up 18.75% at HKD 92.35 [1]. Group 2: Market Position and Strategy - Lin Qingxuan has strategically positioned itself in the high-growth "high-end anti-wrinkle" segment, focusing on the "oil-based skincare" concept with its core product, Camellia Oil, which has dominated the retail market for facial oils in China for 11 consecutive years [4]. - The anti-wrinkle skincare market in China is projected to reach RMB 119.8 billion by 2024, with a compound annual growth rate (CAGR) of 15.0%, significantly outpacing the overall skincare market growth of 6.8% [4]. Group 3: Technological and Competitive Advantages - The company has established a robust technological and industrial chain barrier centered around "cell-level anti-wrinkle" technology, ensuring a competitive edge that is difficult to replicate [5]. - Lin Qingxuan has over 600 formula patents and 87 patents, including 46 invention patents, which cover key areas such as Camellia extraction and anti-wrinkle repair technology [5]. Group 4: Financial Performance - From 2022 to 2024, Lin Qingxuan's revenue is expected to grow from RMB 690 million to RMB 1.21 billion, achieving a CAGR of 32.3%, surpassing the industry average [6]. - In the first half of 2025, the company reported revenue of RMB 1.052 billion, a year-on-year increase of 98.3%, with a net profit of RMB 182 million, nearing the total for 2024 [6]. - The company's gross margin has shown consistent improvement, with figures of 78.0%, 81.2%, 82.5%, and 82.4% from 2022 to the first half of 2025, indicating strong operational effectiveness and market dominance [6]. Group 5: Future Outlook - Lin Qingxuan plans to utilize the raised funds for brand building, marketing, channel expansion, research and quality control, and deepening its industrial chain, which will significantly impact its future growth [7]. - The company's strategic focus on building a strong competitive moat is essential for maintaining its growth trajectory and achieving a dual leap in performance and value [7].

; U 版 您 : U llimm lm 17:30 ulludentulul 18:30 mlll allillahanli 16:15 18:00 17:00 分时 日K 5分 1分 • 行情来源: 利弗莫尔证券 • 林清轩(02657)将于12月30日(周二)在香港挂牌。截至收盘，利弗莫尔证券暗盘交易显示报价91.65港元，较招股价77.77港元上涨17.85%，每手50股，不计 手续费，每手赚694港元。 ...

; U 版 llmm lmannumlill 17:30 rland lilludenial 18:30 rmin 16:15 18:00 17:00 分时 日K 5分 1分 • 行情来源: 利弗莫尔证券 • 智通财经APP获悉，林清轩(02657)将于12月30日(周二)在香港挂牌。截至收盘，利弗莫尔证券暗盘交易显示报价91.65港元，较招股价77.77港元上涨 17.85%，每手50股，不计手续费，每手赚694港元。 ...

上海林清軒化妝品集團股份有限公司 章 程 （草 案） （首 次 公 開 發 行H股 後 適 用） | 第一章 | 總 | | 則 | | 1 | | --- | --- | --- | --- | --- | --- | | 第二章 | | | 經營宗旨和範圍 | | 3 | | 第三章 | 股 | | 份 | | 4 | | 第一節 | | | 股份發行 | | 4 | | 第二節 | | | 股份增減和回購 | | 7 | | 第三節 | | | 股份轉讓 | | 8 | | 第四章 | | | 股東和股東會 | | 10 | | 第一節 | | 股 | 東 | | 10 | | 第二節 | | | 控股股東和實際控制人 | | 15 | | 第三節 | | | 股東會的一般規定 | | 16 | | 第四節 | | | 股東會的召集 | | 19 | | 第五節 | | | 股東會提案和通知 | | 21 | | 第六節 | | | 股東會的召開 | | 23 | | 第七節 | | | 股東會的表決和決議 | | 27 | | 第五章 | | | 董事會 | | 32 | | 第一節 | | 董 | ...

上海林清軒化妝品集團股份有限公司 – 1 – 本 規 則 所 稱 高 級 管 理 人 員，是 指 公 司 總 經 理、副 總 經 理、董 事 會 秘 書、財 務 負 責 人。 董事會提名委員會議事規則 第一條 為 規 範 公 司 董 事 和 高 級 管 理 人 員 的 產 生，優 化 董 事 會 組 成，完 善 公 司 治 理 結 構，根 據《中 華 人 民 共 和 國 公 司 法》（以 下 簡 稱「《公 司 法》」）《香 港 聯 合 交 易 所 有 限 公 司 證 券 上 市 規 則》（以 下 簡 稱「《香 港 上 市 規 則》」）和《上 海 林 清 軒 化 妝 品 集 團 股 份 有 限 公 司 章 程》（以 下 簡 稱「《公 司 章 程》」）等 有 關 規 定，公 司 設 立 董 事 會 提 名 委 員 會，並 制 定 本 議 事 規 則。 第三條 《公 司 法》《香 港 上 市 規 則》《公 司 章 程》關於董事義務的規定適用於提名 委 員 會 委 員。 第二章 人員組成 第四條 提名委員會成員由至少3名 董 事 組 成，其 中 獨 立 非 執 行 董 事 佔 多 數。 第一章 總 則 第二條 董 事 ...